Antihyperglycemic effects of Lysiphyllum strychnifolium leaf extract in vitro and in vivo
AbstractContext Lysiphyllum strychnifolium (Craib) A. Schmitz (LS) (Fabaceae) has traditionally been used to treat diabetes mellitus.Objective This study demonstrates the antidiabetic and antioxidant effects of aqueous extract of LS leaves in vivo and in vitro.Materials and methods The effects of aq...
Main Authors: | Arman Syah Goli, Vilasinee Hirunpanich Sato, Hitoshi Sato, Savita Chewchinda, Jiraporn Leanpolchareanchai, Jannarin Nontakham, Jantana Yahuafai, Thavaree Thilavech, Pongsatorn Meesawatsom, Metawee Maitree |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Pharmaceutical Biology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/13880209.2022.2160771 |
Similar Items
-
Microencapsulation of Lysiphyllum strychnifolium extract using pectin as a carrier matrix and its characterization
by: Arman Syah Goli, et al.
Published: (2022-04-01) -
Oral Glucose Tolerance Test (OGTT) Evidence for the Postprandial Anti-Hyperglycemic Property of <i>Salacca zalacca</i> (Gaertn.) Voss Seed Extract
by: Vilasinee Hirunpanich Sato, et al.
Published: (2023-09-01) -
Antihyperglycemic activity of a novel polyherbal formula (HF344), a mixture of fifteen herb extracts, for the management of type 2 diabetes: Evidence from in vitro, ex vivo, and in vivo studies
by: Worawan Kitphati, et al.
Published: (2024-10-01) -
Inhibitory effects of Triphala on CYP isoforms in vitro and its pharmacokinetic interactions with phenacetin and midazolam in rats
by: Jannarin Nontakham, et al.
Published: (2022-06-01) -
Antidiabetic potential of Lysiphyllum strychnifolium (Craib) A. Schmitz compounds in human intestinal epithelial Caco-2 cells and molecular docking-based approaches
by: Kunwadee Noonong, et al.
Published: (2022-09-01)